This inventor holds 1 USPTO granted patent. Top assignee: Principia Biopharma Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Phillip Lr Nicolson: Patent Activity in Thrombocytopenia Treatment
Introduction
Phillip Lr Nicolson is an inventor associated with Birmingham, Great Britain. His patent work concerns potential treatments for drug-induced thrombocytopenia and vaccine-induced thrombosis and thrombocytopenia syndrome.
Latest Patents
Nicolson is associated with 1 patent: “Methods for Treating Drug and Vaccine Induced Immune Thrombocytopenia by Administering Specific Compounds.” The patent describes methods for treating or preventing drug-induced thrombocytopenia (DITP) and vaccine-induced thrombosis and thrombocytopenia syndrome (VITT) using certain BTK inhibitors or pharmaceutically acceptable salts of those compounds.
Career Highlights
Nicolson is associated with Principia Biopharma Inc. His listed patent reflects research into therapeutic approaches for immune-related platelet disorders.
Collaborations
His listed coworkers include Christopher W Smith and Steve P Watson. Their names are associated with the patent work described above.
Conclusion
Phillip Lr Nicolson’s recorded invention focuses on BTK inhibitor-based approaches to treating or preventing DITP and VITT, representing his documented contribution to pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile